A prospecitve multicenter, observational registry study

Trial Identifier:	D4327R00004
Sponsor:	AstraZeneca
Start Date:	February 2026
Primary Completion Date:	December 2028
Study Completion Date:	December 2028
Condition:	Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
China	Shanghai, China

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.